Psychiatry – Page 14

Evaluating the Patient Health Questionnaire-15 and Somatic Symptom Scale-8: Insights from a Systematic Review and Meta-Analysis

By MedXY 09/23/2025

This article critically reviews measurement properties of the PHQ-15 and SSS-8, two key instruments assessing somatic symptom burden, highlighting reliability, validity, and clinical applicability based on meta-analyzed evidence from over 300 studies.

Clinical Updates news Psychiatry

Theta Burst Stimulation of the Temporo-Parietal Cortex for Persistent Auditory Hallucinations in Schizophrenia: A Comprehensive Review of a Phase 3 Randomised Multicentre Trial and Contextual Evidence

By MedXY 09/21/2025

This review synthesizes evidence on bilateral continuous theta burst stimulation (cTBS) of the temporo-parietal cortex for persistent auditory verbal hallucinations (AVH) in schizophrenia, focusing on a landmark German phase 3 trial demonstrating safety and modest efficacy.

Clinical Updates Family Medicine & Nutrition news Psychiatry Specialties

Add-on Probiotics for Inflammatory Depression: Insights from a Double-Blind Randomized Placebo-Controlled Trial

By MedXY 09/17/2025

This study evaluated the antidepressant effects of a Lactobacillus probiotic in overweight depressed patients with systemic low-grade inflammation, revealing no overall benefit but highlighting fecal formic acid as a potential biomarker for treatment response.

Clinical Updates Family Medicine & Nutrition news Psychiatry Specialties

Enhancing Vagal Nerve Function with Multi-Species Probiotics: A Promising Therapeutic Avenue for Major Depression

By MedXY 09/17/2025

A 3-month RCT demonstrates that multi-species probiotic supplementation improves vagal nerve function, gut microbiome composition, and sleep quality in patients with major depression, suggesting novel gut-brain axis interventions.

AI Clinical Updates news Psychiatry Specialties

Harnessing AI for Personalized Depression Treatment: Insights from the AID-ME Cluster Randomized Trial

By MedXY 09/14/2025

The AID-ME trial demonstrates that an AI-powered clinical decision support system significantly improves remission rates and accelerates symptom improvement in moderate to severe major depressive disorder.

Clinical Updates Psychiatry

Accelerating Depression Recovery: The Impact of Measurement-Based Care in Pakistan’s Low-Resource Settings

By MedXY 09/13/2025

A randomized clinical trial in Pakistan demonstrates that measurement-based care accelerates antidepressant treatment response and remission in major depressive disorder compared to standard care, underscoring its potential in low-resource settings.

Clinical Updates news Psychiatry Specialties

Personalized High-Definition Transcranial Direct Current Stimulation: A Promising Rapid Intervention for Moderate to Severe Depression

By MedXY 09/13/2025

A randomized clinical trial demonstrates that personalized high-definition transcranial direct current stimulation (HD-tDCS) significantly improves mood in patients with moderate to severe depression, showing faster and comparable effect sizes to conventional therapies and also reducing anxiety symptoms.

AI news Psychiatry Specialties

Smart-T Digital Intervention Enhances Smoking Cessation Among Low-Income Adults: Insights from a Randomized Clinical Trial

By MedXY 09/11/2025

The Smart-T smartphone intervention significantly improves 7-day smoking abstinence at 26 weeks in low-income adults, outperforming the standard QuitGuide app when combined with nicotine replacement therapy.

Psychiatry Public Health Specialties

Impact of Graphic Health Warnings on Little Cigar and Cigarillo Use: Evidence from a Randomized Clinical Trial

By MedXY 09/11/2025

A randomized trial demonstrates that graphic health warnings on little cigars and cigarillos significantly increase quitting intentions and related behaviors compared to FDA text-only warnings or no warnings, highlighting the need for enhanced packaging policies.

Psychiatry Specialties

Evaluating the Role of Behavioral Therapy in Enhancing Buprenorphine Treatment Outcomes for Opioid Use Disorder: Insights from a Secondary Analysis of Four Randomized Clinical Trials

By MedXY 09/11/2025

A secondary analysis of four randomized trials reveals that additional behavioral therapy does not significantly improve opioid abstinence, retention, or functional outcomes when added to buprenorphine and medical management in opioid use disorder treatment.

Nursing & care Pediatrics Psychiatry Specialties

Automated Tobacco Cessation for Parents in Pediatric Care: A Cluster-Randomized Trial Insights

By MedXY 09/11/2025

This cluster-randomized trial evaluated an automated tobacco cessation intervention for parents in pediatric primary care, finding no significant increase in 1-year quit rates but notable improvements in treatment engagement and smoking reduction.

news Psychiatry Specialties

Esketamine Monotherapy for Treatment-Resistant Depression: A New Therapeutic Frontier

By MedXY 09/11/2025

A phase 4 randomized trial demonstrates that esketamine nasal spray monotherapy significantly reduces depressive symptoms in adults with treatment-resistant depression, offering a promising alternative to oral antidepressants.

Clinical Updates news Psychiatry Specialties

Cannabidiol Use and Liver Enzyme Elevations: Insights from a Randomized Clinical Trial in Healthy Adults

By MedXY 09/11/2025

A 4-week randomized trial shows that low-dose cannabidiol (CBD) may cause transient liver enzyme elevations in healthy adults, emphasizing the need for vigilance and further safety assessment of consumer CBD products.

Clinical Updates news Psychiatry Specialties

Enhancing Opioid Use Disorder Care in Primary Settings: Impact of an EHR-Integrated Clinical Decision Support System

By MedXY 09/11/2025

A cluster randomized trial demonstrates that an electronic health record–integrated clinical decision support system increases naloxone prescriptions and opioid use disorder treatments in primary care but does not change diagnosis rates or MOUD adherence.

Clinical Updates Psychiatry Rheumatology

Empowering Mental Health in Inflammatory Rheumatic Diseases Through Digital Interventions: Insights from a Pilot Randomized Clinical Trial

By MedXY 09/10/2025

A pilot study demonstrates that a self-guided digital psychological intervention significantly reduces psychological distress and improves quality of life in patients with inflammatory rheumatic diseases, offering a scalable mental health support solution.

Psychiatry Rheumatology Specialties

Harnessing Digital Psychological Interventions to Improve Mental Health in Inflammatory Rheumatic Diseases: Insights from a Pilot Randomized Clinical Trial

By MedXY 09/10/2025

A pilot randomized clinical trial demonstrates that a self-guided digital psychological intervention effectively reduces psychological distress and improves quality of life among patients with inflammatory rheumatic diseases.

Family Medicine & Nutrition news Psychiatry Specialties

Pro-Inflammatory Diets Elevate Risk of Depression and Anxiety: Insights from a Large UK Biobank Study

By MedXY 09/07/2025

A prospective UK Biobank study reveals that diets with higher pro-inflammatory potential, as measured by the Dietary Inflammatory Index, are significantly associated with increased risk of depressive and anxiety symptoms and disorders over 14 years.

news Pediatrics Psychiatry Specialties

Midazolam Outperforms Melatonin as Premedication for Anxiety in Children Undergoing Elective Surgery: Insights from the MAGIC Trial

By MedXY 09/07/2025

The MAGIC trial reveals midazolam’s superior efficacy over melatonin in reducing preoperative anxiety in children undergoing general anaesthesia, despite melatonin’s favorable safety profile. Challenges in recruitment and implications for future research are discussed.

Medical News news Pediatrics Psychiatry Specialties

Unlocking Mental Health in Children with Chronic Illness: The Crucial Roles of Physical Activity and Social Play

By MedXY 09/06/2025

Children with chronic physical illnesses face higher risks of mental health issues, partly due to early-life constraints on social and physical activities. Encouraging active play and social engagement may reduce these risks.

Clinical Updates Gastroenterology news Psychiatry Specialties

Increased Risk of Psychiatric Disorders in Patients with Microscopic Colitis: Insights from a Nationwide Swedish Cohort Study

By MedXY 09/05/2025

A comprehensive Swedish study reveals that patients with microscopic colitis face a significantly higher risk of developing psychiatric disorders such as depression and anxiety, underscoring the importance of holistic clinical management.